NCT07081178

A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany (WeGo Real Germany).

A Non-interventional Study Investigating Semaglutide in Combination With Lifestyle-based Modifications for the Management of Obesity in Real-World Clinical Practice in Germany Non-interventional.

• Status: Enrolling By Invitation
• Phase: —
• Study type: Observational
• Enrollment: 555 (estimated)
• Sponsor: Novo Nordisk A/S · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

Participants will be treated with commercially available semaglutide according to routine clinical practice at the discretion of the treating physician for the management of obesity. The purpose of this study is to collect data on the effect of Semaglutide under everyday conditions in participants. Participants and doctor had already decided that they will get semaglutide prescribed by doctor, independently of patient's participation in this study. The study will last for 12 months.

Conditions

• Obesity

Interventions

Type	Name	Description
DRUG	Semaglutide	Semaglutide injection will be self-administered once weekly subcutaneously at any time of the day with or without meals.

Timeline

• Start date: 2025-08-08
• Primary completion: 2027-10-21
• Completion: 2027-10-21
• First posted: 2025-07-23
• Last updated: 2026-04-07

Locations

1 site across 1 country: Germany